LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

LLY

770.04

+0.64%↑

JNJ

151.32

+1.12%↑

NVO

69.79

-5.51%↓

ABBV

183.89

-0.62%↓

UNH

300.76

-0.36%↓

Search

CareDx Inc

Suletud

SektorTervishoid

18.9 -0.79

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

18.27

Max

19.14

Põhinäitajad

By Trading Economics

Sissetulek

-88M

-10M

Müük

-1.9M

85M

P/E

Sektori keskmine

16.598

50.857

Aktsiakasum

0.1

Kasumimarginaal

-12.225

Töötajad

644

EBITDA

-6.1M

-13M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+31.3% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

30. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

24M

1B

Eelmine avamishind

19.69

Eelmine sulgemishind

18.9

Uudiste sentiment

By Acuity

50%

50%

134 / 381 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Neutral Evidence

CareDx Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. juuni 2025, 18:52 UTC

Tulu

Accenture Shares Fall on Bookings Decline, Concerns over Federal Government Contract -- 3rd Update

22. juuni 2025, 23:59 UTC

Market Talk

Gold Edges Higher Amid Worries Over Middle East Conflict -- Market Talk

22. juuni 2025, 23:55 UTC

Market Talk

Markets Wait to See if Iran's Response Will be Symbolic or Substantial -- Market Talk

22. juuni 2025, 23:51 UTC

Market Talk

Oil Climbs After U.S. Attack on Iran's Nuclear Sites -- Market Talk

22. juuni 2025, 23:43 UTC

Market Talk

Reasons to Believe Strait of Hormuz Will Remain Open -- Market Talk

22. juuni 2025, 23:38 UTC

Market Talk

Nikkei May Fall as Middle East Uncertainty Persists -- Market Talk

22. juuni 2025, 23:11 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22. juuni 2025, 23:11 UTC

Market Talk

Early Market Reaction to Iran Attacks Restrained -- Market Talk

22. juuni 2025, 22:59 UTC

Market Talk

Gold, Silver Rise as Investors Seek Haven After Strikes on Iran -- Market Talk

22. juuni 2025, 21:43 UTC

Market Talk

Australian Govt Says Supports US Strikes On Iran -- Market Talk

21. juuni 2025, 08:20 UTC

Market Talk
Tulu

Tech, Media & Telecom Roundup: Market Talk

21. juuni 2025, 08:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

21. juuni 2025, 08:20 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Financial Services Roundup: Market Talk

20. juuni 2025, 20:50 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Financial Services Roundup: Market Talk

20. juuni 2025, 20:50 UTC

Market Talk
Tulu

Tech, Media & Telecom Roundup: Market Talk

20. juuni 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

20. juuni 2025, 20:13 UTC

Tulu
Omandamised, ülevõtmised, äriostud

These Stocks Moved the Most Today: Tesla, Accenture, GMS, CarMax, Circle Internet, Smith & Wesson, Kroger, and More -- Barrons.com

20. juuni 2025, 20:11 UTC

Market Talk

Natural Gas Slides in Late-Week Profit Taking -- Market Talk

20. juuni 2025, 19:56 UTC

Market Talk

Crude Oil Slips to End Week -- Market Talk

20. juuni 2025, 18:35 UTC

Market Talk

Warehouse Clubs Seen Growing Market Share -- Market Talk

20. juuni 2025, 18:12 UTC

Market Talk

Gold Slides to Close Shortened Week -- Market Talk

20. juuni 2025, 17:56 UTC

Market Talk

Baker Hughes Reports Slight Decrease in U.S. Rig Count -- Market Talk

20. juuni 2025, 17:50 UTC

Tulu
Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Tesla, Accenture, GMS, CarMax, Circle Internet, Smith & Wesson, Kroger, and More -- Barrons.com

20. juuni 2025, 17:35 UTC

Omandamised, ülevõtmised, äriostud

Cisco Was the Dot-Com Bust's Biggest Loser. Now It's at a 25-Year High. -- Barrons.com

20. juuni 2025, 17:30 UTC

Market Talk
Tulu

Adobe's AI Headwinds Seen Fading -- Market Talk

20. juuni 2025, 17:03 UTC

Tulu

Accenture Earnings Beat Expectations. Why the Stock Is Falling Anyway. -- Barrons.com

20. juuni 2025, 16:50 UTC

Market Talk
Tulu

Global Equities Roundup: Market Talk

20. juuni 2025, 16:50 UTC

Market Talk
Tulu

Accenture Seeing Companies Shift to Leapfrog Mentality -- Market Talk

20. juuni 2025, 16:44 UTC

Omandamised, ülevõtmised, äriostud

Meet QXO, the Upstart Building Materials Stock That May Battle Home Depot for GMS -- Barrons.com

20. juuni 2025, 16:40 UTC

Market Talk
Tulu

Accenture Can't Yet Estimate Longer Term Impact from Federal Cuts -- Market Talk

Võrdlus sarnastega

Hinnamuutus

CareDx Inc Prognoos

Hinnasiht

By TipRanks

31.3% tõus

12 kuu keskmine prognoos

Keskmine 25 USD  31.3%

Kõrge 30 USD

Madal 19 USD

Põhineb 5 Wall Streeti analüütiku instrumendi CareDx Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

5 ratings

2

Osta

2

Hoia

1

Müü

Tehniline skoor

By Trading Central

14.77 / 18.49Toetus ja vastupanu

Lühikene perspektiiv

Neutral Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

134 / 381 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.